Moderna
MRNA
#1187
Rank
C$22.11 B
Marketcap
$57.47
Share price
7.48%
Change (1 day)
-46.31%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2024 (TTM): -C$5.86 Billion

According to Moderna 's latest financial reports the company's current earnings are C$4.98 Billion. In 2023 the company made an earning of -C$5.46 Billion a decrease over its 2022 earnings that were of C$13.42 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$5.86 Billion7.36%
2023 -C$5.46 Billion-140.65%
2022 C$13.42 B-27.81%
2021 C$18.59 B-1911.15%
2020 -C$1.03 Billion44.7%
2019 -C$0.71 Billion28.63%
2018 -C$0.56 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$48.93 Million-99.19%๐Ÿ‡บ๐Ÿ‡ธ USA
C$23.05 B-483.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$58.39 Million-99.03%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.27 Billion-95.66%๐Ÿ‡บ๐Ÿ‡ธ USA
C$17.79 B-395.82%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-C$0.74 Billion-87.79%๐Ÿ‡บ๐Ÿ‡ธ USA
C$25.71 B-527.39%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.17 Billion-97.27%๐Ÿ‡บ๐Ÿ‡ธ USA